UEG's educational platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

UEG Week Berlin 2025 Recordings Gut Guide online

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

SMOKING HABITS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

SMOKING HABITS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Dania Rocio Diaz-Rodriguez 1, Monica Granados Martin 2, Liliana La Rosa-Huertas 3, Inés Constanze Hammel 4

Affiliations

1 Hospital Universitario del Henares, Madrid, Spain

2 Hospital de Fuenlabrada, Fuenlabrada, Spain

3 Universidad Señor de Sipán, Lims, Peru

4 Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain

Summary

AI Generated

Cross-sectional study of 116 IBD patients in Madrid found 24% active smoking prevalence and a statistically significant association between smoking and both anxiety and depression.

Among active smokers, 85.7% had anxiety and 52.7% had depression, and bilateral analysis confirmed smoking was associated with anxiety and depression but not with other sociodemographic or disease variables.
Active smoking prevalence (24%) was higher than the 21.9% rate in the general Madrid population, and 60% were ex-smokers, a much higher proportion than in non-IBD populations.
Among active smokers, 64% were women, 57% had Crohn's disease, 46% were in remission, 64.3% consumed alcohol regularly, and 57.1% did not exercise.
The presenter emphasised that smoking is a risk factor for more severe Crohn's disease course and that nurses should routinely ask about smoking habits and advise cessation, taking psychological factors into account.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Smoking is an environmental and conductual risk factor for the development of Chron’s Disease (CD) and is associated with a more severe course of CD. In contrast, a protective effect is shown in the development and a mild course of Ulcerative Colitis (UC). Smoking leads to cardiovascular disease, cancer and other chronic diseases, and social isolation, anxiety and depression. It is also a predictor of poorer adherence to treatment in young patients.

Results & Findings

50% were women, 52 years old (SD: 12.6). 58.6% suffered CD, 39.7% more than 10 years from onset of disease, 60.7% with biologics; 54.4% in remission and 29.8% mild activity. 24% were active smokers, 60% ex-smokers and 15.5% has never smoked. 60.3% were regular exercisers, and 66% consume alcoholic beverages regularly.
Of those who smoked, 64% were women, 57% suffered CD, 46% was in remission. 85.7% with anxiety and 52.7% with depression, 61.5% perceived their health status as suboptimal. 64.3% consumed alcoholic beverages, 57.1% no physical exercise.
The mean anxiety score was 9 (SD: 3.6), depression score was 5.76 (SD: 3.7). 67.2% had anxiety levels and 32.8% depression. Perceived health status as optimal was 57.9%.
In the bilateral analysis between smoking and the independent variables, only depression and anxiety was associated.

Summary & Discussion

Smoking is an environmental risk factor for the development and course of CD. The aim of this study iis to determine smoking habits and associated factors in patients with Inflammatory Bowel Disease (IBD) in Hospital Universitario del Henares (Madrid).
A transversal study was carried out. Data were collected in a questionnaire ad-hoc and HADS.
Patients with IBD are active smokers, and their percentage is bigger to regular population in Comunidad de Madrid (21.9%). On the other hand, the percentage of ex-smokers with IBD (60%) is much higher than with no IBD; it may be related to IBD development.
It is well known the relationship between IBD and psicosocial aspects. In this study we show the high prevalence of anxiety and depression, which is higher than in general population.
Nurses can play an important role in the psychological care of patients with IBD, especially in prevention and early detection.

Conclusion

Patients with IBD showed a high tobacco consumption, most of which were women and with no healthy habits.
Smoking in patients with IBD is associated with anxiety and depression.

References

(1) Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022;19(11):717-726.
(2) Feng L, Cai X, Zou Q, et al. Exploring the management and treatment of IBD from the perspective of psychological comorbidities. Therap Adv Gastroenterol. 2024;17:17562848241290685.
(3) Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, et al. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients. Gastroenterol Hepatol. 2018;41(2):118-127.
(4) Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25(4):277-83.
(5) Comunidad de Madrid. Dirección de Salud Pública. Resultados del Sistema de Vigilancia Integral del Tabaquismo (VITa). Informe 2023.

Event

UEG Week Berlin 2025

Topics

Nurses

Submission format

Abstract

Session

Abstracts II: Patient care and endoscopic techniques

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Mesenchymal stem cell therapy: All just rubbish?

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens 1

Affiliations

1 Academic Medical Center, Amsterdam, Netherlands

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Berlin 2025

Topics

IBD Mechanisms & Personalised Medicine Surgery

Session

Focus on fistulising Crohn’s disease

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse 1

Affiliations

1 Amsterdam University Medical Center, Amsterdam, Netherlands

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Berlin 2025

Topics

IBD Mechanisms & Personalised Medicine Surgery

Session

Focus on fistulising Crohn’s disease

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Optimising surgical therapies in fistulising Crohn's disease

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer 1

Affiliations

1 St Marks Hospital, London, United Kingdom

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Berlin 2025

Topics

IBD Mechanisms & Personalised Medicine Surgery

Session

Focus on fistulising Crohn’s disease

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

The pregnant IBD patient (Complete Session)

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

The pregnant IBD patient (Complete Session)

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Berlin 2025

Topics

IBD Paediatrics

Session

The pregnant IBD patient

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

How to boost your biology? Every day strategies to improve therapies and combinations

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund 1

Affiliations

1 Charité - Universitätsmedizin Berlin, Berlin, Germany

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Berlin 2025

Topics

IBD Mechanisms & Personalised Medicine Surgery

Session

How to optimise success in IBD treatment

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Benedetta Masoni 1, Arianna Dal Buono 1, Roberto Gabbiadini 2, Giuseppe Privitera 1, gianluca franchellucci 2, Cristina Bezzio 1, Alessandro Repici 3, Alessandro Armuzzi 1

Affiliations

1 IRCCS Humanitas Research Hospital, Rozzano, Italy|||Humanitas University, Pieve Emanuele, Italy

2 IRCCS Humanitas Research Hospital, Rozzano, Italy

3 Humanitas University, Pieve Emanuele, Italy|||IRCCS Humanitas Research Hospital, Rozzano, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

The global burden of Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is increasing. Due to its chronic nature, IBD entails long-term healthcare resource use, contributing to substantial economic and environmental costs. Digestive endoscopy, while a cornerstone of disease monitoring, is associated with high energy consumption, greenhouse gas (GHG) emissions, and medical waste. Intestinal ultrasound (IUS) has emerged as a non-invasive, accurate, and potentially more sustainable alternative.

Aims & Methods

The present study aimed to compare the environmental impacts in terms of CO₂ emissions, energy consumption (kWh), and disposable waste of IUS and endoscopy for therapeutic monitoring in IBD. In this single-center, retrospective observational study conducted at IRCCS Humanitas Research Hospital (Rozzano, Milan), all consecutive IUS and lower gastrointestinal endoscopies performed for therapeutic monitoring in IBD patients between January 2022 and December 2025 were included. Procedures for oncologic surveillance in long-standing disease, isolated rectal involvement (<15 cm from the anal verge), or without confirmed IBD were excluded. Clinical and procedural data were collected. Environmental metrics such as CO₂ emissions, energy consumption (kWh), and disposable waste were estimated using validated conversion factors and compared using appropriate statistical tests (Independent-samples t-test or Mann–Whitney U test).

Results

Endoscopic procedures performed during study period (n=2698)
↓
Exclusion criteria
- Endoscopic procedures in trial setting (n=1157)
-Endoscopic surveillance in UC (n= 216)
-Pouchoscopies & ulcerative proctitis monitoring (n=162)
- Operative/ emergency procedures (n=71)
↓
Endoscopic procedures included in the analysis (n=1092)
Colonoscopies (n= 710)↵ ↳ Sigmoidoscopies (n=382)

intestinal ultrasounds performed during study period (n=1541)
↓
Exclusion criteria
- Indications other than disease monitoring/ patient BMI> 30 Kg/m² (n= 231)
↓
Intestinal ultrasounds included in the analysis (n=1310)

Flowchart 1. Visual representation of the process of selecting procedures to be included in the final analysis. UC: Ulcerative colitis; BMI: Body Mass Index.

During the study period, a total of 1092 endoscopic procedures, comprising 710 colonoscopies and 382 sigmoidoscopies, along with 1310 IUS were performed in 1028 IBD patients (58% UC, 42% CD). Estimated resource use for all endoscopic procedures totaled 1,256 kWh of electricity, 72,080 L of CO₂ emissions, and 585.6 kg of disposable waste, based on procedural averages (~1.5 kWh, 80 L of CO₂, 650 g waste per colonoscopy; ~50% of values for sigmoidoscopies). In contrast, IUS was associated with an estimated 524 kWh of electricity and 196.5 kg of disposable waste (average ~0.4 kWh, almost no CO₂ consumption, 150 g waste per exam). Compared to endoscopy, IUS reduced energy use by 82%, CO₂ emissions by 95%, and waste generation by 66% (P < 0.05 for all comparisons).

Conclusion

While gastrointestinal endoscopy remains indispensable in certain clinical scenarios, its environmental impact is considerable. In contrast, IUS emits almost no equivalent of CO₂, consumes significantly less energy per examination and produces negligible wastes. For therapeutic monitoring in IBD, IUS has demonstrated high diagnostic accuracy with a markedly lower ecological footprint. These findings promote IUS as a sustainable and environmentally friendly alternative for routine IBD monitoring in appropriate scenarios.

Disclosure

A Armuzzi has received consulting and/or advisory board fees from AbbVie, Allergan, Amgen, Arena, Biogen, Bristol-Myers Squibb, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz, Takeda, lecture and/or speaker bureau fees from AbbVie, Amgen, Arena, Biogen, Bristol-Myers Squibb, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mitsubishi Tanabe, Novartis, Pfizer, Roche, Sandoz, Takeda, Tigenix, and research grants from MSD, Pfizer, Takeda and Biogen. A Repici received consulting fee from Medtronic, Fuji and Olympus and has received research grant from Alfa Sigma, Norgine, Boston and Erbe. C Bezzio received speaker’s fees and consulting fees from for Takeda, MSD, Ferring, Abbvie, Galapagos and Janssen. A Dal Buono has received speaker’s fees from Pfizer, MSD, Eli-Lilly, Celltrion, Janssen, and consulting fees from Ferring. R Gabbiadini has received speaker’s fees from Pfizer, MSD, Ferring, Eli-Lilly, Celltrion, Janssen, consulting fees from Pfizer and Abbvie. G. Privitera has received speaker’s fees from Janssen and Alphasigma. B. Masoni and G. Franchellucci declare no conflict of interests.

Event

UEG Week Berlin 2025

Topics

IBD Radiology & Imaging

Submission format

Abstract

Session

Monitoring IBD by imaging

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

More Like This:

Mesenchymal stem cell therapy: All just rubbish?

Christianne Johanna Buskens

Which advanced therapy should you choose in patients with fistulising Crohn's disease?

Krisztina Barbara Gecse

Optimising surgical therapies in fistulising Crohn's disease

Philip J. Tozer

The pregnant IBD patient (Complete Session)

How to boost your biology? Every day strategies to improve therapies and combinations

Britta Siegmund

ENVIRONMENTAL IMPACT OF INTESTINAL ULTRASOUND COMPARED WITH ENDOSCOPY IN THE MONITORING OF INFLAMMATORY BOWEL DISEASE

Alessandro Armuzzi

UEG's educational platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

Most popular content

Rate for better recommendations!